Tolvaptan in hospitalized cancer patients with hyponatremia: A double‐blind, randomized, placebo‐controlled clinical trial on efficacy and safety

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|120|5|744-751

ISSN: 0008-543x

Source: CANCER, Vol.120, Iss.5, 2014-03, pp. : 744-751

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content